Cutler Group LP Pmv Pharmaceuticals, Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Cutler Group LP holds 2,500 shares of PMVP stock, worth $2,375. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 2,500
-0.0%
Holding current value
$2,375
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PMVP
# of Institutions
63Shares Held
40.2MCall Options Held
1.8KPut Options Held
100-
Orbimed Advisors LLC San Diego, CA6.48MShares$6.15 Million0.22% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.75MShares$3.56 Million3.31% of portfolio
-
Sio Capital Management, LLC New York, NY3.74MShares$3.55 Million1.53% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.31MShares$3.14 Million0.07% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.3MShares$3.14 Million0.29% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $43.3M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...